Geisinger Announces Big Data Genomics Project | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Geisinger Announces Big Data Genomics Project

January 13, 2014
by Gabriel Perna
| Reprints

Geisinger Health System, the large Danville, Pa.-based integrated health system, is throwing its hat into the genetics game, announcing a large-scale big data collaboration with Regeneron Pharmaceuticals, a Tarrytown, N.Y.-based biopharmaceutical company.

In the five year collaboration, Geisinger aims to collect samples from more than 100,000 consented patient volunteers, while Regeneron performs sequencing and genotyping to generate de-identified genomic data. To date, this will be one of the larger studied population of participants for the analysis and sequencing of genetic material and comparison to long-term health outcomes in the U.S.

The aim of the collaboration will focus on patients with chronic conditions, according to David H. Ledbetter, Ph.D., executive vice president and chief scientific officer of Geisinger Health System. In a prepared statement, Dr. Ledbetter said this collaboration has the potential to provide the system with tools to transform its ability to foresee disease before the onset of symptoms, diagnose chronic and potentially fatal conditions before it's too late to intervene, and determine how best to optimize the health and well-being for each of its patients.

Geisinger is just the latest healthcare organization to make a personalized medicine. In May of last year, New York’s  Mount Sinai Medical Center announced that 25,000 people signed on to participate in its biobank program, BioMe, where each patient has broadly consented to DNA sequencing, contact from researchers, and longitudinal studies related to data embedded in the electronic medical record (EMR). 

Also last year, Cerner, the Kansas City-based EMR vendor, announced it was teaming with Cambridge, Mass.-based Claritas Genomics, a clinical genetic diagnostic testing company, to integrate personalized medicine technology into clinical practice.

 

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).